Characterization of the genotoxic profile of antineoplastic drugs using the cytokinesis-block micronucleus cytome assay

Ilana Struys, Eline Verscheure, Liesbeth Lenaerts, Frédéric Amant, Lode Godderis, Manosij Ghosh

Research output: Contribution to journalArticleAcademicpeer-review


Since antineoplastic agents are frequently used in cancer therapy and able to affect the patient's DNA, it is important to know the genotoxic consequences on non-cancerous tissue. Therefore, we aimed to characterize the genotoxic profile of antineoplastic drugs belonging to different classes, using the cytokinesis-block micronucleus cytome assay in a human monocytic cell line (THP-1). All tested antineoplastic agents resulted in increased micronucleus formation. Exposure to anthracyclines led to an increased number of vacuolated cells and cell death, while for mitotic spindle inhibitors, (different stages of) cell death and an increased nuclear bud formation was observed. Alkylating agents induce a high proportion of vacuolated cells and increased nuclear bud formation. No striking differences of nuclear division index or nucleoplasmic bridge formation were observed between exposed and non-exposed cells. The here presented class-specific aberrations may facilitate interpretation of genotoxic aberrations when evaluating clinical samples from patients treated with these antineoplastic agents.
Original languageEnglish
Article number104036
JournalEnvironmental toxicology and pharmacology
Publication statusPublished - 1 Jan 2023


  • Antineoplastic drug
  • Cytokinesis-block micronucleus cytome assay
  • Genotoxicity
  • Micronucleus

Cite this